期刊文献+

增殖细胞核抗原小干扰RNA对人结肠癌CaCO_2细胞抑制作用 被引量:4

Inhibitory effect of proliferating cell nuclear antigen small interfering RNA on human colon carci- noma CaCO_2 cells
原文传递
导出
摘要 目的观察增殖细胞核抗原(PCNA)小干扰RNA(siRNA)对人结肠癌CaCO_2细胞抑制作用。方法WST-8法和克隆形成抑制研究No.2和No.4 PCNA siRNA对CaCO_2细胞的作用;碘化丙锭(PI)单染检测细胞周期,Hochest33258染色观察凋亡形态,膜联蛋白(Annexin)V和PI双染测定凋亡百分率。结果No.2和No.4 PCNA siRNA与CaCO_2细胞作用,增殖抑制率分别为(72.24±1.01)%和(74.67±3.35)%;克隆形成抑制率均达90%;两种药物转染细胞均出现明显亚二倍体峰,Sub-G_1+G_0/G_1期减少,S+G_2/M期增多;siRNA处理组细胞有较多凋亡形态变化;凋亡率随浓度增加而增加,且早期凋亡率持续高于晚期凋亡/坏死率。结论PCNA siRNA显著抑制人结肠癌CaCO_2细胞增殖及克隆形成;细胞停留于G_2/M期,明显诱导细胞凋亡。 Objective To explore the inhibitory effect of proliferating cell nuclear antigen ( PC- NA) small interfering RNA (siRNA) on human colon carcinoma CaCO2 cells. Methods WST-S assay and colony formation inhibitory assay were employed to detect the inhibitory effect of No. 2 and No. 4 PC-NA siRNA on CaCO2 cells. Flow cytometry was used to examine the cell cycle using propidium iodide (PI) dying. Morphological changes of apoptotic cells were observed under a fluorescent microscope with hochest33258 staining. AnnexinV-PI dying was applied to detect the percentage of apoptotic cells. Results After activation of either No. 2 or No. 4 PCNA siRNA with CaCO2 cells, the proliferating inhibitory rates were (72.24 ± 1.01 ) % and (74.67 ± 3.35 ) %, respectively and the inhibitory rates of colony formation all reached to 90% ;After transfected with the two agents respectively ,the CaCO2 cells all displayed Sub-G1 apeptotic peaks obviously,reduction at Sub-G1 + G0/G1 phase and the increase at S + G2/M phase; More apoptotic morphologicgl changes were observed in both siRNA treatment groups. The apoptotic rate was increased in consistent with the increasing concentration of No. 2 siRNA. The percentage of early apoptotic cells was continuously higher thatt late apoptotic and necrosis cells. Conclusion PCNA siRNA significantly inhibited human colon CaCO2 cell proliferation and colony formation, which was contributed to the cell cycle arresting at G2/M phase, and predominant induction of cell apoptosis.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2007年第4期454-456,F0003,共4页 Chinese Journal of Experimental Surgery
基金 广州市科技计划资助项目(2002J1-C0361)
关键词 增殖细胞核抗原 小干扰RNA 结肠癌 Proliferating cell nuclear antigen siRNA Colon carcinoma
  • 相关文献

参考文献7

二级参考文献20

  • 1蔡讯,陈芳源,韩洁英,顾春红,钟华,滕晔,欧阳仁荣.槲皮素逆转白血病细胞株K562/ADM多药耐药的研究[J].肿瘤,2004,24(4):354-357. 被引量:18
  • 2李臣宾 ,张峰 ,史玉荣 ,魏熙胤 ,杨毅 ,牛瑞芳 .小干扰RNA引发多药耐药乳腺癌细胞内MDR1基因沉默的研究[J].中华实验外科杂志,2004,21(10):1199-1201. 被引量:18
  • 3Elbashir SM, Harborth J, Lendeckel W, et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells.Nature,2001,411:494-498.
  • 4Harborth J,Elabshir SM, Bechert K, et al. Identification of essential genes in cultured mammalian cells using small interfering RNAs. J Cell Sci, 2001,114:4557-4565.
  • 5Sakakura C,Hagiwara A,Tsujimoto H,et al.Ihibition of gastric cancer cell proliferation by antisense oligonucleotides targeting the messenger RNA encoding proliferating cell nuclear antigen.Br J Cancer,1994,70:1060-1066.
  • 6Wianny F, Zernicka-Goetz M. Specific interference with gene function by double-stranded RNA in early mouse development.Nat Cell Biol,2000,2:70-75.
  • 7Wilda M,Fuchs U,Wossmann W,et al.Killing of leukemic cells with a BCR/ABL fusion gene by RNA interference(RNAi).Oncogene,2002,21:5716-5724.
  • 8Miyagish M,Taira K.U6 promoter-driven shRNAs with four uridine 3'overhangs efficiently suppress targeted gene expression in mammaliance cells.Nature Biotechnology, 2001,19:497-498.
  • 9Brummelkamp TR,Bernards R,Agami R.A system for stable expression of short interfering RNAs in mammaliance cells. Science,2002,296:550-553.
  • 10Kotb M,Kredich NM.S-Adenosyylmethionine synthease from human lymphocytes.Purification and characterization.J Biol Chem,1985,260:3923-3930.

共引文献33

同被引文献38

  • 1王芳,蒋建伟,陈涛,曹明溶.聚乙烯亚胺介导生存素反义核酸体外投递肝癌SMMC-7721细胞的条件优化[J].暨南大学学报(自然科学与医学版),2006,27(4):551-556. 被引量:9
  • 2张其亮,杨述华,刘红云,吴翠环.增殖细胞核抗原短发夹状RNA对人骨肉瘤细胞生长的影响[J].中华病理学杂志,2005,34(3):167-170. 被引量:4
  • 3黄光胜,曾慧兰,蒋建伟,曹明溶,严玉霞,何文珊.半乳糖受体介导的PCNA反义核酸提高肝癌细胞对化疗药物的敏感性[J].广东医学,2005,26(4):455-457. 被引量:4
  • 4徐连根,潭洁,耿伟,沈志祥.凋亡相关基因caspase-9,bax及bcl-2在大肠癌中的表达及其意义[J].临床消化病杂志,2006,18(1):25-27. 被引量:7
  • 5ASTUDILLO H, LOPEZ T, CASTILLO S, et al. p53, Bcl-2, PCNA expression, and apoptotic rates during cervical tumorigenesis [J]. Ann N Y Aead Sci, 2003, 10 (10) :771 -774.
  • 6TAFTACHI R, AYHAN A, EKICI S, et al. Proliferating-cell nuclear antigen (PCNA) as an independent prognostic marker inpatients after prostatectomy: a comparison of PCNA and Ki-67 [ J ]. B J U Int, 2005, 95 (4) :650 -654.
  • 7GAYLE E, WOLOSCHAK, TATJANA P. Deficient PCNA expression and radiation semitivity[ J]. Inter Con Seties, 2002, 1236(4): 249-253.
  • 8GEORGE VZD, NIKOLAOS K. Glutathione depletion restores the susceptibility of eisplafin-resistant chronic myelogenous leukemia cell lines to Natural Killer cell-mediated cell death via necrosis rather than apoptosis[ J]. Eur J of Cell Biol, 2001, 80(9) : 608 -614 .
  • 9GROSSI F, LOPREVITE M, CHIARAMONDIA M, et al. Prognostic significance of K-ras, p53, bcl-2, PCNA, CD34 in radically resected non-small cell lung cancers [J]. Eur J Cancer, 2003, 39(9) :1242 - 1250.
  • 10GEORGE K, WU S Y, DANIELLA I. Structural and biochemical studies of human proliferating cell nuclear antigen complexes provide a rationale for cychn association and inhibitor design[J]. Proc Natl Acad Sci, 2005, 102 (6) : 1871 - 1876.

引证文献4

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部